DOI: 10.11648/j.cnn.20261003.12 ISSN: 2578-8930

Lytico-Bodig in Guam: A Mysterious Neurological Disease

Claire Liu
Show PDF Cite
Lytico-Bodig disease, also known as Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex (ALS-PDC), is a rare neurodegenerative disorder uniquely affecting the Chamorro people of Guam. This review analyzes its historical context, epidemiology, clinical features, proposed causes, and ongoing research. First identified in the mid-20th century, Lytico-Bodig combines ALS-like motor symptoms, parkinsonism, and dementia, with notable clinical variability. It disproportionately affects certain Chamorro families and villages, suggesting genetic and environmental influences. The disease peaked in the 1950s–60s as a leading cause of death. Although the incidence has dramatically declined, cases persist, reflecting its public health relevance. While environmental factors, notably cycad seeds and flying foxes containing the neurotoxin β-methylamino-L-alanine (BMAA), along with genetic susceptibility are strongly implicated, the causal link between BMAA and the disease remains a subject of ongoing scientific debate and uncertainty. Neuropathological findings show neuronal loss, tau protein deposits, and neurofibrillary tangles, similar to Alzheimer’s and Parkinson’s diseases. Diagnosis is difficult due to symptom overlap with other conditions, and treatment remains supportive. Its progressive nature imposes a heavy burden on caregivers, underscoring the need for robust support systems. Ultimately, Lytico-Bodig remains a complex disorder requiring continued research, improved healthcare strategies, and community involvement to improve outcomes for affected individuals.

More from our Archive